Hersey P, Edwards A, McCarthy W H
Int J Cancer. 1980 Feb 15;25(2):187-94. doi: 10.1002/ijc.2910250204.
The influence of tumour growth on the natural killer (NK) activity of melanoma patients was examined by analysis of NK activity in 51Cr release assays before and at intervals after surgical removal of localized melanoma. In patients with Stage I and II melanoma, removal of the tumour was associated with changes in the level of NK activity which were not detected in patients who had surgery for skin graft after previous removal of the primary melanoma. The changes in NK activity after removal of melanoma were however different in patients with Stage I compared to Stage II melanoma. In the former, NK activity which appeared specifically directed toward melanoma cells was maximal 2-4 weeks after removal of the tumour and then decreased to normal levels. The NK activity after surgery was directly related to the thickness of the tumour. In patients with Stage II melanoma, NK activity did not increase but fell to low levels after removal of the tumour. The level of NK activity in these patients was not related to the thickness of their primary melanoma. In patients with Stage I and II melanoma the NK activity against melanoma cells showed a significant increase with age. The reason for the different sequence of changes in NK activity after removal of melanoma in the two patient groups is unknown. It is suggested however that the differences observed in patients with Stage II melanoma may reflect differences in the tumour or host response which contributed to the spread of the tumour to regional lymph nodes in these patients.
通过对51例局限性黑色素瘤患者手术切除前后不同时间间隔的51Cr释放试验中自然杀伤(NK)活性进行分析,研究肿瘤生长对黑色素瘤患者NK活性的影响。在I期和II期黑色素瘤患者中,肿瘤切除与NK活性水平的变化有关,而在先前切除原发性黑色素瘤后进行皮肤移植手术的患者中未检测到这种变化。然而,I期黑色素瘤患者与II期黑色素瘤患者切除黑色素瘤后NK活性的变化不同。在前者中,似乎特异性针对黑色素瘤细胞的NK活性在肿瘤切除后2 - 4周达到最大值,然后降至正常水平。手术后的NK活性与肿瘤厚度直接相关。在II期黑色素瘤患者中,NK活性没有增加,而是在肿瘤切除后降至低水平。这些患者的NK活性水平与原发性黑色素瘤的厚度无关。在I期和II期黑色素瘤患者中,针对黑色素瘤细胞的NK活性随年龄显著增加。两组患者切除黑色素瘤后NK活性变化顺序不同的原因尚不清楚。然而,有人认为,II期黑色素瘤患者中观察到的差异可能反映了肿瘤或宿主反应的差异,这些差异导致了肿瘤在这些患者中扩散至区域淋巴结。